How to buy Asensus Surgical stock - 14 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Asensus Surgical stock

Own Asensus Surgical stock in just a few minutes.

Asensus Surgical, Inc is a medical devices business based in the US. Asensus Surgical shares (TRXC) are listed on the NYSE MKT and all prices are listed in US Dollars. Asensus Surgical employs 160 staff and has a trailing 12-month revenue of around USD$2.8 million.

How to buy shares in Asensus Surgical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Asensus Surgical. Find the stock by name or ticker symbol: TRXC. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Asensus Surgical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Asensus Surgical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Asensus Surgical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Asensus Surgical share price

Use our graph to track the performance of TRXC stocks over time.

Asensus Surgical shares at a glance

Information last updated 2021-03-10.
52-week rangeUSD$0.28 - USD$6.88
50-day moving average USD$4.1503
200-day moving average USD$1.461
Wall St. target priceUSD$1.45
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.338

Buy Asensus Surgical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
N/A
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Asensus Surgical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Asensus Surgical financials

Revenue TTM USD$2.8 million
Gross profit TTM USD$-4,792,000
Return on assets TTM -44.58%
Return on equity TTM -94.1%
Profit margin 0%
Book value $0.622
Market capitalisation USD$916.9 million

TTM: trailing 12 months

Shorting Asensus Surgical shares

There are currently 6.7 million Asensus Surgical shares held short by investors – that's known as Asensus Surgical's "short interest". This figure is 26.9% down from 9.2 million last month.

There are a few different ways that this level of interest in shorting Asensus Surgical shares can be evaluated.

Asensus Surgical's "short interest ratio" (SIR)

Asensus Surgical's "short interest ratio" (SIR) is the quantity of Asensus Surgical shares currently shorted divided by the average quantity of Asensus Surgical shares traded daily (recently around 48.2 million). Asensus Surgical's SIR currently stands at 0.14. In other words for every 100,000 Asensus Surgical shares traded daily on the market, roughly 140 shares are currently held short.

However Asensus Surgical's short interest can also be evaluated against the total number of Asensus Surgical shares, or, against the total number of tradable Asensus Surgical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Asensus Surgical's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Asensus Surgical shares in existence, roughly 30 shares are currently held short) or 0.0302% of the tradable shares (for every 100,000 tradable Asensus Surgical shares, roughly 30 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Asensus Surgical.

Find out more about how you can short Asensus Surgical stock.

Asensus Surgical share dividends

We're not expecting Asensus Surgical to pay a dividend over the next 12 months.

Have Asensus Surgical's shares ever split?

Asensus Surgical's shares were split on a 1:13 basis on 11 December 2019. So if you had owned 13 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Asensus Surgical shares – just the quantity. However, indirectly, the new 1200% higher share price could have impacted the market appetite for Asensus Surgical shares which in turn could have impacted Asensus Surgical's share price.

Asensus Surgical share price volatility

Over the last 12 months, Asensus Surgical's shares have ranged in value from as little as $0.28 up to $6.88. A popular way to gauge a stock's volatility is its "beta".

TRXC.US volatility(beta: 1.98)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Asensus Surgical's is 1.9772. This would suggest that Asensus Surgical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Asensus Surgical overview

Asensus Surgical, Inc. engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. It digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through a new category of care called Digital Laparoscopy. The company's digital interface enables the use of capabilities, such as augmented intelligence, connectivity, and robotics in laparoscopy, as well as allows to address the current clinical, cognitive, and economic shortcomings in surgery. The company's products include Senhance Surgical System, a multi-port robotic surgery system that allows multiple robotic arms to control instruments and a camera; and SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform. It offers its products directly and through distributors in Europe, the United States, Japan, Taiwan, and internationally. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is based in Morrisville, North Carolina.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site